Nu Skin Enterprises Inc. (NYSE:NUS) has been given an average rating of “Hold” by the eleven research firms that are presently covering the stock. Three analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $53.90.

A number of research firms have recently weighed in on NUS. Stifel Nicolaus raised their price target on shares of Nu Skin Enterprises from $34.00 to $45.00 and gave the stock a “sell” rating in a research report on Friday, August 5th. Citigroup Inc. raised their price target on shares of Nu Skin Enterprises from $52.00 to $61.00 and gave the stock a “buy” rating in a research report on Friday, August 5th. Jefferies Group raised their price target on shares of Nu Skin Enterprises from $53.00 to $61.00 and gave the stock a “hold” rating in a research report on Thursday, September 22nd. Bank of America Corp. set a $56.00 price target on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a research report on Sunday, November 6th. Finally, Deutsche Bank AG reissued a “hold” rating and set a $55.00 price target (up previously from $45.00) on shares of Nu Skin Enterprises in a research report on Sunday, July 24th.

Nu Skin Enterprises (NYSE:NUS) opened at 52.60 on Thursday. The company’s 50 day moving average is $61.75 and its 200-day moving average is $52.17. Nu Skin Enterprises has a 1-year low of $23.51 and a 1-year high of $66.04. The stock has a market cap of $2.86 billion, a PE ratio of 21.28 and a beta of 1.75.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, November 3rd. The company reported $0.98 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.84 by $0.14. Nu Skin Enterprises had a net margin of 6.26% and a return on equity of 20.06%. The company earned $604 million during the quarter, compared to the consensus estimate of $583.74 million. During the same quarter last year, the company earned $0.71 earnings per share. Nu Skin Enterprises’s revenue for the quarter was up 5.7% on a year-over-year basis. Equities research analysts forecast that Nu Skin Enterprises will post $2.95 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Friday, November 18th will be paid a $0.355 dividend. This represents a $1.42 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date of this dividend is Wednesday, November 16th. Nu Skin Enterprises’s payout ratio is 57.96%.

In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 30,000 shares of the firm’s stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $64.13, for a total value of $1,923,900.00. Following the sale, the director now directly owns 36,090 shares in the company, valued at $2,314,451.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Steven Lund sold 61,000 shares of the firm’s stock in a transaction on Wednesday, October 26th. The shares were sold at an average price of $61.55, for a total value of $3,754,550.00. The disclosure for this sale can be found here. 4.60% of the stock is owned by company insiders.

Large investors have recently bought and sold shares of the stock. Washington Trust Bank boosted its stake in Nu Skin Enterprises by 0.6% in the third quarter. Washington Trust Bank now owns 2,011 shares of the company’s stock worth $130,000 after buying an additional 11 shares during the last quarter. Metropolitan Life Insurance Co. NY raised its position in shares of Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares during the period. Utah Retirement Systems raised its position in shares of Nu Skin Enterprises by 1.0% in the third quarter. Utah Retirement Systems now owns 10,000 shares of the company’s stock worth $648,000 after buying an additional 100 shares during the period. First Quadrant L P CA raised its position in shares of Nu Skin Enterprises by 0.5% in the second quarter. First Quadrant L P CA now owns 23,323 shares of the company’s stock worth $1,077,000 after buying an additional 123 shares during the period. Finally, BOKF NA raised its position in shares of Nu Skin Enterprises by 3.4% in the third quarter. BOKF NA now owns 8,689 shares of the company’s stock worth $563,000 after buying an additional 286 shares during the period. Institutional investors own 77.11% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

5 Day Chart for NYSE:NUS

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.